Relyea Zuckerberg Hanson LLC Merck & Co., Inc. Transaction History

Relyea Zuckerberg Hanson LLC

$656 Million
Q3 2024

A detailed history of Relyea Zuckerberg Hanson LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Relyea Zuckerberg Hanson LLC holds 8,680 shares of MRK stock, worth $895,081. This represents 0.15% of its overall portfolio holdings.

Number of Shares

8,680

Previous 9,286 6.53%

Holding current value

$895,081

Previous $1.15 Million 14.27%

% of portfolio

0.15%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$111.15 - $128.97 $67,356 - $78,155	-606 Reduced 6.53%	8,680 $985,000
Q2 2024 Oct 31, 2024	BUY	$123.8 - $132.96 $106,715 - $114,611	862 Added 10.23%	9,286 $1.15 Million
Q2 2024 Jul 17, 2024	BUY	$123.8 - $132.96 $106,715 - $114,611	862 Added 10.23%	9,286 $1.15 Million
Q1 2024 Oct 31, 2024	BUY	$113.24 - $131.95 $43,937 - $51,196	388 Added 4.83%	8,424 $1.11 Million
Q1 2024 Apr 22, 2024	BUY	$113.24 - $131.95 $43,937 - $51,196	388 Added 4.83%	8,424 $1.11 Million
Q4 2023 Oct 31, 2024	SELL	$100.18 - $109.02 $22,340 - $24,311	-223 Reduced 2.7%	8,036 $876,000
Q4 2023 Jan 18, 2024	SELL	$100.18 - $109.02 $22,340 - $24,311	-223 Reduced 2.7%	8,036 $876,000
Q3 2023 Oct 31, 2024	SELL	$102.95 - $114.33 $43,341 - $48,132	-421 Reduced 4.85%	8,259 $850,000
Q3 2023 Oct 16, 2023	BUY	$102.95 - $114.33 $15,030 - $16,692	146 Added 1.8%	8,259 $850,000
Q2 2023 Jul 17, 2023	BUY	$108.61 - $118.38 $13,141 - $14,323	121 Added 1.51%	8,113 $936,000
Q1 2023 Apr 18, 2023	BUY	$102.94 - $114.86 $79,263 - $88,442	770 Added 10.66%	7,992 $850,000
Q4 2022 Jan 18, 2023	BUY	$87.44 - $112.11 $102,829 - $131,841	1,176 Added 19.45%	7,222 $0
Q3 2022 Nov 02, 2022	BUY	$84.53 - $94.96 $32,544 - $36,559	385 Added 6.8%	6,046 $521,000
Q2 2022 Jul 18, 2022	BUY	$83.49 - $94.64 $35,566 - $40,316	426 Added 8.14%	5,661 $516,000
Q1 2022 Apr 19, 2022	BUY	$73.51 - $82.4 $101,590 - $113,876	1,382 Added 35.87%	5,235 $451,000
Q4 2021 Jan 27, 2022	BUY	$72.28 - $90.54 $24,719 - $30,964	342 Added 9.74%	3,853 $308,000
Q4 2021 Jan 14, 2022	BUY	$72.28 - $90.54 $1,734 - $2,172	24 Added 0.69%	3,511 $287,000
Q3 2021 Oct 22, 2021	BUY	$71.68 - $78.83 $29,675 - $32,635	414 Added 13.47%	3,487 $262,000
Q2 2021 Jul 23, 2021	BUY	$70.31 - $77.77 $17,999 - $19,909	256 Added 9.09%	3,073 $239,000
Q1 2021 Apr 29, 2021	SELL	$68.86 - $81.11 $47,788 - $56,290	-694 Reduced 19.77%	2,817 $218,000
Q4 2020 Jan 28, 2021	SELL	$71.77 - $79.65 $4,665 - $5,177	-65 Reduced 1.82%	3,511 $287,000
Q3 2020 Oct 16, 2020	BUY	$73.18 - $82.95 $4,756 - $5,391	65 Added 1.85%	3,576 $283,000
Q2 2020 Jul 13, 2020	SELL	$70.42 - $80.13 $7,957 - $9,054	-113 Reduced 3.12%	3,511 $272,000
Q4 2019 Jan 15, 2020	BUY	$77.58 - $87.54 $281,149 - $317,244	3,624 New	3,624 $330,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Relyea Zuckerberg Hanson LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relyea Zuckerberg Hanson LLC with notifications on news.

Account

Relyea Zuckerberg Hanson LLC Merck & Co., Inc. Transaction History